Dimitrios Magouliotis

I am a fifth-year CT Surgery resident at the University Hospital of Larissa, Greece.

After my graduation from Medical School in 2016, I completed a sub-internship in general and laparoscopic surgery at the Bnai Zion Medical Center, Haifa, Israel. Following my internship, I continued my postgraduate studies with an M.Sc. Degree in “Clinical Applications of Molecular Medicine” at the University of Thessaly, Larissa, Greece in collaboration with the Warren Alpert Medical School of Brown University (10/17-11/18).

I began my seven-year cardiothoracic residency program (three years in general surgery, and four years in cardiothoracic surgery) at the Department of Surgery, University Hospital of Larissa, in February 2017. In this context, I visited as a Fellow (stagiaire medical) the Centre Hépato-Biliaire Paul Brousse in Paris, under the supervision of Prof. René Adam to be exposed to liver/pancreatic transplantations and advanced laparoscopic and oncologic surgery.

In 2020 I completed my second M.Sc. Degree in Perioperative Medicine at University College London (UCL) under the supervision of Prof. David Walker. During my studies I was exposed to the whole spectrum of perioperative medicine, designing and implementing quality improvement interventions, measuring quality, validating risk stratification tools, and implementing a shared-decision making strategy in the clinical practice.

From November 2020 I have been allocated at the Department of Cardiothoracic Surgery, University of Thessaly, under the Supervision of Prof. Thanos Athanasiou. During my post, I have significantly contributed to the restructuring of the Department, using quality improvement interventions with significant outcomes (our morbidity and mortality rates are significantly lower compared to the historical rates of the Department prior to our posts). We have also initiated the first Unit of Quality Improvement in CT Surgery in Greece and in this context, we have published numerous articles, book chapters and have presented several abstracts in international congresses. In the same context, I was selected for EACTS/FFF Quality and Outcomes 2022 Fellowship in Ann Arbor, Michigan, under the supervision of Dr. Richard Prager.

In March 2023 I have successfully defended my Ph.D. Thesis in the establishment of Patient-Derived Xenografts as preclinical models of cancer, at the University of Thessaly.

Finally, I study an MBA Degree at the University of Nicosia.

My current academic Metrics include over 95 Pubmed-indexed publications, h-index:18, and i10-index: 27